Blue Cloud Softech Solutions Limited Empaneled by BSNL as a Captive Non-Public Network Provider

▴ Blue Cloud Softech Solutions Limited
Empanelment enables BCSSL to participate in enterprise private network and digital connectivity projects across India.

Hyderabad, India – 29 June 2026: Blue Cloud Softech Solutions Limited (“BCSSL” or “the Company”), an AI-first technology company listed on BSE Limited (Scrip Code: 539607), has been empaneled by Bharat Sanchar Nigam Limited (“BSNL”) as a Captive Non-Public Network Provider under Category III, for the provision of Captive Non-Public Network (CNPN) services to enterprise customers across India.

 

The empanelment follows the execution of a formal agreement between BSNL and BCSSL, enabling the Company to collaborate with BSNL in planning, designing, deploying, commissioning and maintaining captive private network solutions for enterprise customers. The agreement is valid for a period of 60 months, subject to the terms and conditions contained therein.

 

The empanelment confers on the Company eligibility to participate in enterprise CNPN projects in association with BSNL. It does not, by itself, guarantee any specific business or revenue, and the financial impact, if any, will depend on the projects actually secured.

 

Captive Non-Public Networks are emerging as an important component of India’s digital transformation, enabling enterprises to deploy secure, reliable and dedicated communication networks tailored to their operational requirements. Such networks are expected to support Industry 4.0 initiatives, smart manufacturing, logistics automation, mission-critical communications and digital enterprise applications.

 

Under the empanelment framework, BCSSL will be eligible to partner with BSNL across its areas of operation for enterprise CNPN projects, strengthening the Company’s position in the evolving private network ecosystem and creating opportunities to deliver connectivity solutions to enterprises across multiple industry sectors.

 

Management Commentary

Commenting on the development, the Management of Blue Cloud Softech Solutions Limited stated:

“We are pleased to be empaneled by BSNL as a Captive Non-Public Network Provider. This reflects our technological capabilities and our commitment to supporting India’s digital infrastructure. We look forward to working with BSNL and enterprise customers to deploy secure, scalable, reliable and next-generation private network solutions that drive operational efficiency and digital transformation.

 

Strategic Significance

•      Strengthens BCSSL’s presence in the telecommunications and enterprise technology ecosystem.

•      Enables participation in the growing market for private 4G/5G and enterprise network solutions.

•      Creates opportunities across manufacturing, logistics, utilities, healthcare, smart campuses, mining and other enterprise sectors.

•      Supports India’s vision of accelerating digital transformation and the adoption of advanced communication technologies.

 

“This empanelment further strengthens the Company’s telecom capabilities following the grant of its DoT Unified Licence (VNO) and positions Blue Cloud to participate in emerging enterprise private network opportunities across smart manufacturing, logistics, healthcare, utilities, industrial IoT and AI-enabled digital infrastructure. It reinforces the Company’s long-term strategy of delivering advanced enterprise connectivity and next-generation digital transformation solutions across multiple industry sectors.”

 

This paragraph is concise, adds strategic value, and remains consistent with SEBI-compliant disclosure language.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-






Trending Now

Healthcare Leaders Share Industry Insights Shaping IndiaJuly 04, 2026
Warning Signs Your Body Gives Before Serious IllnessJuly 04, 2026
Diabetes Prevention Tips for Indians: A Practical GuideJuly 03, 2026
Superbugs and Global Health: India's Growing AMR CrisisJuly 03, 2026
Navigating a New Cancer Diagnosis: Oncologists & Pathways July 02, 2026
Skin Allergies in the Monsoon: Common Triggers and TreatmentsJuly 02, 2026
The Growing Problem of Antibiotic Resistance in IndiaJuly 02, 2026
Future of Healthcare in India: Doctors on AI and CareJuly 02, 2026
High Blood Pressure: Causes, Symptoms and Prevention GuideJuly 02, 2026
CARE Hospitals Celebrates National Doctors' Day, Honours Doctors for Their Commitment to Saving LivesJuly 01, 2026
Ancient Wisdom Meets Modern Science at Happiest Health’s ‘Ayurveda & Gut’ EventJuly 01, 2026
Estrogen Replacement Therapy Market Size to Reach USD 19.4 Billion by 2034 at a 5.7% CAGR from 2026 to 2034July 01, 2026
MGM Healthcare and MGM Cancer Institute announced an exclusive Master Health and Vaccination Package for Blood Donors.July 01, 2026
QR678® Enters European Market with Germany as Strategic Launchpad for QR678 X-PRO®July 01, 2026
Patient Experience in Healthcare: Why It Matters in IndiaJuly 01, 2026
Antibiotic Resistance in India: Causes, Risks and SolutionsJuly 01, 2026
The Truth About Antibiotics: Why You Should Never Self-Medicate July 01, 2026
The Role of Microbiome in Gut Health and ImmunityJuly 01, 2026
Understanding Autoimmune Diseases: Why Your Body Attacks Itself July 01, 2026
Thyroid Cancer: Early Signs, Diagnosis, and Treatment in IndiaJuly 01, 2026